177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
177Lu-PSMA-I&T for Metastatic Castration-Resistant Prostate Cancer	Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder	Active, not recruiting	Phase 3	2026-09-04		NCT05204927

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Curium US LLC	4

52 results · Page 1 of 3

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Arizona Institute of Urology, PPLC	Tucson	United States	1
ASST Grande Ospedale Metropolitano Niguarda	Milan	Italy	29
BAMF Health I PC	Grand Rapids	United States	1
Biogenix Molecular LLC	Miami	United States	3
Center for Clinical Theranostics Research, Washington University	St Louis	United States	1
Central Ohio Urology Group	Gahanna	United States	14
CHU Brest	Brest	France	37
CHU Nimes	Nîmes	France	8
Columbia University Medical Center - Herbert Irving Pavilion	New York	United States	6
Florida Urology Partners, LLP	Tampa	United States	1
Fred Hutchinson Cancer Center	Seattle	United States	250
Fundación Jiménez Díaz	Madrid	Spain	10
GenesisCare USA	Troy	United States	2
GenesisCare USA	Plantation	United States	1
GenesisCare USA	Boca Raton	United States	1
Henry Ford Hospital	Detroit	United States	326
Hightower Clinical	Oklahoma City	United States	19
Hoag Memorial Hospital Presbyterian	Newport Beach	United States	66
Hospital Regional Universitario de Malaga	Málaga	Spain	10
Hospital Universitario HM Sanchinarro	Madrid	Spain	9
Houston Metro Urology	Houston	United States	27
Hôpital de Brabois -CHU	Nancy	France	1
Icahn School of Medicine at Mount Sinai	New York	United States	342
ICANS	Strasbourg	France	10
Institut de Cancérologie de l'Ouest (ICO) St Herblain	Nantes	France	1

Clinical trials